About optimeo16

This author has not yet filled in any details.
So far optimeo16 has created 73 blog entries.

LSX Nordic Congress, Stockholm, Sweden, August 29-30, 2018

By |August, 2018|

LSX Nordic Congress, Stockholm, Sweden, August 29-30, 2018


Please meet us at the LSX Nordic Congress in Stockholm, Sweden. LSX Nordic is a high-calibre, senior executive conference and partnering event providing the education, strategies, solutions, and contacts that life science companies need to enable more effective investment, business planning and partnering within their businesses.

BioPharm America 2018

By |August, 2018|

BioPharm America 2018, Boston, MA, USA, September 5-6, 2018

Please meet us at the 2018 BioPharm America in Boston. BioPharm America is the only event in North America based on the same reputable formula as European events BIO-Europe and BIO-Europe Spring.

NLSDays 2018

By |August, 2018|

NLSDays 2018, Stockholm, Sweden, September 10-12, 2018

Please meet us at 2018 NLSDay conference in Stockholm Waterfront. Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place to do business.

XIV International Pharma Licensing Symposium, Montreux, Switzerland, September 19-21, 2018

By |September, 2018|

XIV International Pharma Licensing Symposium, Montreux, Switzerland, September 19-21, 2018

Please meet us at the  XIV International Pharma Licensing Symposium that will take place at Fairmont Le Montreux Palace in the stunning surroundings of Montreux, Switzerland. The event allows for the opportunity to hold pre-arranged partnering meetings and attend the presentations from high-calibre key note speakers. Participants also have the option of joining one of two additional training workshops being run in parallel to the one-to-one meetings.

Xplico article for Biotech & Money / LSX

By |August, 2018|

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, gives his point of view on the challenges that the Nordic life science companies face.

Xplico is pleased to announce that Sisse Ramsing Escargueil has joined our team

By |August, 2018|

Xplico is pleased to announce that Sisse Ramsing Escargueil has joined our team as Executive Assistant and will be working closely together with the partners Uffe Boesen and Finn Nikolajsen.
Sisse holds a Master’s Degree in International Business Relations and has more than 18 years of experience from Sales Management (B2C and B2B) and Business Administration. She has previous experience as both Executive Assistant and Personal Assistant and has worked with business development, sales management, market analysis and financial research in Denmark, France and USA.

XIV International Pharma Licensing Symposium, Montreux, Switzerland, September 19-21, 2018

By |September, 2018|

XIV International Pharma Licensing Symposium, Montreux, Switzerland, September 19-21, 2018

Please meet us at the  XIV International Pharma Licensing Symposium that will take place at Fairmont Le Montreux Palace in the stunning surroundings of Montreux, Switzerland. The event allows for the opportunity to hold pre-arranged partnering meetings and attend the presentations from high-calibre key note speakers. Participants also have the option of joining one of two additional training workshops being run in parallel to the one-to-one meetings.

LSX World Congress USA in Boston, October 10-11, 2018

By |August, 2018|

LSX World Congress USA in Boston, October 10-11, 2018


Please meet us at the LSX World Congress USA in Boston. LSX World Congress USA is a high-calibre, senior executive conference and partnering event providing the education, strategies, solutions, and contacts that life science companies need to enable more effective investment, business planning and partnering within their businesses.

BIO-Europe 2018, Copenhagen, Denmark, November 5-7, 2018

By |August, 2018|

BIO-Europe 2018, Copenhagen, Denmark, November 5-7, 2018

Please meet us at the 2018 International Partnering Conference in our hometown Copenhagen, Denmark. BIO-Europe is Europe’s largest partnering conference, serving the global biotechnology industry. The conference annually attracts international leaders from biotech, pharma and finance along with the most promising start-ups and emerging companies.

Biofit 2018, Lille, France, December 4-5, 2018

By |August, 2018|

Biofit 2018, Lille, France, December 4-5, 2018

Please meet us at 2018 Biofit conference in Lille. BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences

Biotech Showcase 2019, San Francisco, USA, January 7–9, 2019

By |August, 2018|

Biotech Showcase 2019, San Francisco, USA, January 7–9, 2019


Please meet us at the 2019 Biotech Showcase in San Francisco. The investor and networking conference for public and private biotech companies to meet with and present to investors and pharmaceutical executives during the course of the healthcare industry’s most important week of the year.

BIO-Europe Spring 2019, Vienna, Austria, March 25 – 27, 2019

By |August, 2018|

BIO-Europe Spring 2019, Vienna, Austria, March 25 – 27, 2019


Please meet us at the 2019 BIO-Europe Spring Partnering Conference in Vienna, Austria. With a focus on European innovation and global collaboration, BIO-Europe Spring is the premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in the most innovative biopharma clusters in Europe

Xplico Interview with Biotech & Money / LSX

By |July, 2018|

In an interview with Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, explains how valuation is critical for strategic decision-making and points out to some of the common pitfalls companies encounter when using valuation models that are built in house.
The link to the interview: Xplico: supporting strategic decision-making through life science valuations

Xplico named “a 2017 Gazelle Company” (a growth company) for the second year in a row by the leading Danish business newspaper Boersen.

By |February, 2018|

We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2017 Gazelle Company for the 2nd year in a row. Boersen analyses every year all the Danish companies to identify growth companies. A Gazelle company is defined by the growth in revenue every year for a minimum of four consecutive years. Further, the revenue needs to be doubled in the period of four years and the company generate a profit. We plan to stay on the Gazelle list for the coming years.

 

(September 2017)

Xplico is pleased to announce that Golnaz Borghei has joined our valuation team.

By |February, 2018|

Golnaz has 10+ years’ experience in biotech and medtech research and industry. She holds a PhD in Analytical Biotechnology from Cambridge University followed by several years of research in physiology at Cambridge and Oxford universities in collaboration with Pharmaceuticals. For the last 5 years, Golnaz has been in Commercialization, Technology & Market Assessment, Competitor Analysis and Business Evaluation in life science industry and has been advisor to life science investors. She is certified in Executive Finance from Harvard Business School.


(June 2017)

Xplico named “a 2016 Gazelle Company” (a growth company) by the leading Danish business newspaper Boersen.

By |January, 2017|

We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2016 Gazelle Company. Børsen analyses every year all the Danish companies to identify growth companies. A Gazelle company is defined by the growth in revenue every year for a minimum of 4 consecutive years. Further, the revenue needs to be doubled in the period of 4 years and the company must generate a profit. We plan to stay on the Gazelle list for the coming years.
(September 2016)

Xplico is pleased to announce that Peter Abelin has joined our valuation team.

By |January, 2017|

Xplico is pleased to announce that Peter Abelin has joined our valuation team.
Peter has more than 25 years’ experience from the life science industry working with equity portfolio management, financial research and pharmaceutical development at Swedbank Robur, AMF Pension, SEB Enskilda, Astra AB and as an MD. Peter brings a lot of expertise in assessing equity investments and life science equity valuation and will work closely with our clients valuating their business. Peter has combined his MD with BSc Econ and CE Financial Analyst.

skaermbillede-2017-01-04-kl-16-01-04
(June 2016)

BIO-Europe Spring 2017

By |November, 2016|

BIO-Europe Spring 2017, Barcelona, Spain, March 20 – 22, 2018

Please meet us at BIO-Europe Spring Partnering Conference in Barcelona Spain. BIO-Europe Spring is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe, and continues the tradition of providing life science companies with high calibre partnering opportunities.

Deal supported by Xplico

By |October, 2016|

PharmaMar and Boryung Pharm sign a licensing agreement for Aplidin® (plitidepsin) in Korea.

Deal supported by Xplico

By |October, 2016|

Nuevolution Announces Strategic Collaboration with Amgen in Oncology and Neuroscience.

Deal supported by Xplico

By |October, 2016|

Sarepta Therapeutics and Summit Enter Into Exclusive License and Collaboration Agreement for European Rights to Summit’s Utrophin Modulator Pipeline for the Treatment of Duchenne Muscular Dystrophy.

Deal supported by Xplico

By |October, 2016|

TRACON Pharmaceuticals Announces a Strategic Licensing Collaboration for Two Janssen Oncology Assets and a $5 Million Equity Investment from Johnson & Johnson Innovation – JJDC, Inc.

BIO International Convention

By |October, 2016|

2017 BIO International Convention, San Diego, USA, June 19-22, 2017

Please meet us at the 2016 BIO International Convention in San Francisco, USA. The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.

Spin-out supported by Xplico

By |September, 2016|

4SC sells immunology portfolio to Immunic